Please login to the form below

Not currently logged in
Email:
Password:

Clostridium difficile

This page shows the latest Clostridium difficile news and features for those working in and with pharma, biotech and healthcare.

Pfizer drug gets speedy FDA review for rare heart failure complication

Pfizer drug gets speedy FDA review for rare heart failure complication

products including the company’s Clostridium difficile vaccine and nerve growth factor-targeting tanezumab for severe pain.

Latest news

More from news
Approximately 4 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    Nestlé has been granted commercial rights (outside the USA and Canada) to a range of products focusing on Clostridium difficile infections (CDI) including SER 109 and SER 262 as well as ... 32, 000. Seres Therapeutics/ Nestle Health Science.

  • Astellas: Ten years young Astellas: Ten years young

    class of OAB treatments to emerge in over 30 years, the antifungal Mycamine (micafungin) and the anti-infective Dificlir - the first new treatment in 50 years for clostridium difficile or c.

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    x. Hospital-acquired bacterial pneumonia (HABP)/ventilator-associated bacterial pneumonia (VABP). x. surotomycin. Pneumonia Clostridium difficile-associated diarrhoea (CDAD).

  • Pharma deals during December 2014 Pharma deals during December 2014

    The Optimer acquisition brought to Cubist an approved antibacterial drug for the treatment of Clostridium difficile-associated diarrhoea (CDAD) called DIFICID (fidaxomicin).

  • Pharma deals during July 2013 Pharma deals during July 2013

    Cubist had already developed a relationship with Optimer through their 2011 co-promotion agreement for Dificid (fidaxomicin), for the treatment of Clostridium difficile-associated diarrhoea (CDAD) in adults 18 years of

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics